U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130994) titled 'Reduction of Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)' on Aug. 08.
Brief Summary: CASSINI-US is a prospective, single-arm, multicenter early feasibility study enrolling up to 15 patients at up to 5 sites in the United States (US).
The purpose of the study is to evaluate the technical (implant) feasibility, and safety, and performance of the SATURN TS TMVR System for the treatment of moderate-severe or severe, symptomatic mitral regurgitation through a transcatheter approach.
Primary objectives evaluate the implant feasibility, and acute safety and performance of the SATURN TS TMVR System. The se...